Not recruiting
Age-related macular degeneration
Not recruitingStudy on the Effectiveness of Bevacizumab and Ranibizumab in Treating Age-Related Macular Degeneration in Patients with Genetic Variations
Registered drugNo placebo
Study on the Effectiveness of Bevacizumab and Ranibizumab in Treating Age-Related Macular Degeneration in Patients with Genetic Variations
Registered drugNo placebo
- Disease:Age-related macular degeneration
- Substances:BevacizumabRanibizumab
Countries:
Spain
Spain- Participants:18–64 years
- Substances:Bevacizumab




